Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer.

Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. — المؤلف: Xiao, Roy — Oncoimmunology

المؤلف
Xiao, Roy
النشر
Oncoimmunology
الوصف
e1471440 p.